Home » Topics » Regulatory » Health Canada

Health Canada
RSS

Canadian authorities assessing reimbursement for newly approved cystic fibrosis treatment Kalydeco

Dec. 4, 2012

Health Canada approves Cymbalta for pain associated with osteoarthritis of the knee

Nov. 13, 2012

Health Canada approves Seebri Breezhaler for COPD

Oct. 23, 2012

Health Canada approves new drug submission for Cinryze

Oct. 23, 2012

New safety information for Zofran issued in Canada

Oct. 10, 2012

Apricus Biosciences plans Canadian submission for MycoVa

Oct. 2, 2012

Health Canada approves Dermagraft for diabetic foot ulcers

Sep. 7, 2012

Health Canada approves Treanda

Aug. 29, 2012

Tarceva approved in Canada for specific NSCLC subtype

Aug. 14, 2012

Xiaflex approved in Canada

July 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...